EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Relationship Between Early-Pregnancy Glycemia and Adverse Outcomes: Findings From the TOBOGM Study

Arianne Sweeting iD, Joanne Enticott, Jincy Immanuel, William M Hague iD, Helena Teede iD, Christopher J Nolan iD, Michael J Peek, Jeff R Flack, Mark McLean iD, Vincent W Wong iD, Emily J Hibbert, Alexandra Kautzky-Willer iD und 7 weitere

Diabetes Care · 01.12.2024 · 47 (12) · 2085-2092

DOI: 10.2337/dc23-2214 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Care, online erschienen am 31.07.2024. Verfasst von Arianne Sweeting und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Royal Prince Alfred Hospital and University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Diabetes, Gestational, Blood Glucose, Glucose Tolerance Test. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Western Sydney University Ainsworth Trust Grant 2019, Region Örebro Research Committee, Medical Scientific Fund of the Mayor of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE We evaluated associations between early-pregnancy oral glucose tolerance test (OGTT) glucose and complications in the Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) cohort to inform prognostic OGTT thresholds. RESEARCH DESIGN AND METHODS Individuals with risk factors for hyperglycemia were recruited for an international, multicenter, randomized controlled gestational diabetes mellitus (GDM) (World Health Organization 2013 criteria) treatment trial. A 2-h 75-g OGTT was performed at <20 weeks’ gestation. Individuals with early treated hyperglycemia in pregnancy were excluded from the primary analysis. Early OGTT glucose concentrations were analyzed continuously and in glycemic categories (normal, low band, and high band). RESULTS Overall, 3,645 individuals had an OGTT at (mean ± SD) 15.6 ± 2.5 weeks. For each 1-SD increase in fasting, 1-h, and 2-h glucose values, there were continuous positive associations with late GDM: adjusted odds ratio (aOR) 2.04 (95% CI 1.82–2.27), 3.05 (2.72–3.43), and 2.21 (1.99–2.45), respectively. There were continuous positive associations between 1-h and 2-h glucose and the perinatal composite (birth <37 + 0 weeks, birth trauma, birth weight ≥4,500 g, respiratory distress, phototherapy requirement, stillbirth/neonatal death, and shoulder dystocia), with aOR 1.15 (95% CI 1.04–1.26) and 1.14 (1.04–1.25), respectively, and with large-for-gestational-age offspring, with aOR 1.18 (1.06–1.31) and 1.26 (1.01–1.25), respectively. Significant associations were also observed between 1-h glucose and cesarean section and between fasting and 2-h glucose and neonatal hypoglycemia. In categorical analysis, only the high-band 1-h glucose (≥10.6 mmol/L [191 mg/dL]) predicted the perinatal composite. CONCLUSIONS There is a continuous positive association between early-pregnancy OGTT glucose and complications. In individuals with hyperglycemia risk factors, only the high-glycemic-band 1-h glucose corresponded to increased risk of major perinatal complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalBlood GlucoseGlucose Tolerance TestHumansFemalePregnancyAdultHyperglycemiaPregnancy OutcomeInfant, NewbornRisk Factors

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Endocrinology, Royal Prince Alfred Hospital and University of Sydney, Sydney, New South Wales, Australia.
  • Monash University, Melbourne, Victoria, Australia.
  • Western Sydney University, Campbelltown, New South Wales, Australia.
  • Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
  • Canberra Hospital and Australian National University, Canberra, Australia Capital Territory, Australia.
  • Australian National University, Canberra, Australia Capital Territory, Australia.

ORCID-Profile: Arianne Sweeting, William M Hague, Helena Teede, Christopher J Nolan, Mark McLean, Vincent W Wong, Alexandra Kautzky-Willer, Jürgen Harreiter, Helena Backman, Viswanathan Mohan

Förderung

  • Western Sydney University Ainsworth Trust Grant 2019
  • Region Örebro Research Committee
  • Medical Scientific Fund of the Mayor of Vienna
  • South Western Sydney Local Health District Academic Unit 2016
  • National Health and Medical Research Council
  • Australian Diabetes Association Skip Martin Early Career Fellowship

Zitieren

APA

Sweeting, A., Enticott, J., Immanuel, J., Hague, W. M., Teede, H., Nolan, C. J., Peek, M. J., Flack, J. R., McLean, M., Wong, V. W., Hibbert, E. J., Kautzky-Willer, A., Harreiter, J., Backman, H., Gianatti, E., Mohan, V., Cheung, N. W., Simmons, D., & TOBOGM Research Group (2024). Relationship Between Early-Pregnancy Glycemia and Adverse Outcomes: Findings From the TOBOGM Study. Diabetes Care, 47(12), 2085-2092. https://doi.org/10.2337/dc23-2214

Vancouver

Sweeting A, Enticott J, Immanuel J, Hague WM, Teede H, Nolan CJ, et al. Relationship Between Early-Pregnancy Glycemia and Adverse Outcomes: Findings From the TOBOGM Study. Diabetes Care. 2024;47(12):2085-2092. doi:10.2337/dc23-2214

BibTeX
@article{Sweeting2024,
  author = {Sweeting, Arianne and Enticott, Joanne and Immanuel, Jincy and Hague, William M and Teede, Helena and Nolan, Christopher J and Peek, Michael J and Flack, Jeff R and McLean, Mark and Wong, Vincent W and Hibbert, Emily J and Kautzky-Willer, Alexandra and Harreiter, Jürgen and Backman, Helena and Gianatti, Emily and Mohan, Viswanathan and Cheung, N Wah and Simmons, David and TOBOGM Research Group, TOBOGM Research Group},
  title = {Relationship Between Early-Pregnancy Glycemia and Adverse Outcomes: Findings From the TOBOGM Study},
  journal = {Diabetes Care},
  year = {2024},
  volume = {47},
  number = {12},
  pages = {2085--2092},
  doi = {10.2337/dc23-2214}
}
Kostenlos starten →